Determination of type I receptor specificity by the type II receptors for TGF-beta or activin - PubMed (original) (raw)

. 1993 Nov 5;262(5135):900-2.

doi: 10.1126/science.8235612.

Affiliations

• PMID: 8235612
• DOI: 10.1126/science.8235612

Determination of type I receptor specificity by the type II receptors for TGF-beta or activin

R Ebner et al. Science. 1993.

Abstract

Transforming growth factor-beta (TGF-beta) and activin signal primarily through interaction with type I and type II receptors, which are transmembrane serine-threonine kinases. Tsk 7L is a type I receptor for TGF-beta and requires coexpression of the type II TGF-beta receptor for ligand binding. Tsk 7L also specifically bound activin, when coexpressed with the type IIA activin receptor. Tsk 7L could associate with either type II receptor and the ligand binding specificity of Tsk 7L was conferred by the type II receptor. Tsk 7L can therefore act as type I receptor for both activin and TGF-beta, and possibly other ligands.

PubMed Disclaimer

Similar articles

• Identification of human activin and TGF beta type I receptors that form heteromeric kinase complexes with type II receptors.
  Attisano L, Cárcamo J, Ventura F, Weis FM, Massagué J, Wrana JL. Attisano L, et al. Cell. 1993 Nov 19;75(4):671-80. doi: 10.1016/0092-8674(93)90488-c. Cell. 1993. PMID: 8242742
• Characterization of type I receptors for transforming growth factor-beta and activin.
  ten Dijke P, Yamashita H, Ichijo H, Franzén P, Laiho M, Miyazono K, Heldin CH. ten Dijke P, et al. Science. 1994 Apr 1;264(5155):101-4. doi: 10.1126/science.8140412. Science. 1994. PMID: 8140412
• The p21(RAS) farnesyltransferase alpha subunit in TGF-beta and activin signaling.
  Wang T, Danielson PD, Li BY, Shah PC, Kim SD, Donahoe PK. Wang T, et al. Science. 1996 Feb 23;271(5252):1120-2. doi: 10.1126/science.271.5252.1120. Science. 1996. PMID: 8599089
• Three-finger toxin fold for the extracellular ligand-binding domain of the type II activin receptor serine kinase.
  Greenwald J, Fischer WH, Vale WW, Choe S. Greenwald J, et al. Nat Struct Biol. 1999 Jan;6(1):18-22. doi: 10.1038/4887. Nat Struct Biol. 1999. PMID: 9886286 Review.
• Tgf-beta superfamily and mouse craniofacial development: interplay of morphogenetic proteins and receptor signaling controls normal formation of the face.
  Dudas M, Kaartinen V. Dudas M, et al. Curr Top Dev Biol. 2005;66:65-133. doi: 10.1016/S0070-2153(05)66003-6. Curr Top Dev Biol. 2005. PMID: 15797452 Review. No abstract available.

Cited by

• Smad transcription factors as mediators of 7 transmembrane G protein-coupled receptor signalling.
  Chia ZJ, Kumarapperuma H, Zhang R, Little PJ, Kamato D. Chia ZJ, et al. Acta Pharmacol Sin. 2024 Nov 6. doi: 10.1038/s41401-024-01413-6. Online ahead of print. Acta Pharmacol Sin. 2024. PMID: 39506064 Review.
• How Activin A Became a Therapeutic Target in Fibrodysplasia Ossificans Progressiva.
  Srinivasan D, Arostegui M, Goebel EJ, Hart KN, Aykul S, Lees-Shepard JB, Idone V, Hatsell SJ, Economides AN. Srinivasan D, et al. Biomolecules. 2024 Jan 12;14(1):101. doi: 10.3390/biom14010101. Biomolecules. 2024. PMID: 38254701 Free PMC article. Review.
• The Fate of Leydig Cells in Men with Spermatogenic Failure.
  Adamczewska D, Słowikowska-Hilczer J, Walczak-Jędrzejowska R. Adamczewska D, et al. Life (Basel). 2022 Apr 12;12(4):570. doi: 10.3390/life12040570. Life (Basel). 2022. PMID: 35455061 Free PMC article. Review.
• Immune Inhibitory Properties and Therapeutic Prospects of Transforming Growth Factor-Beta and Interleukin 10 in Autoimmune Hepatitis.
  Czaja AJ. Czaja AJ. Dig Dis Sci. 2022 Apr;67(4):1163-1186. doi: 10.1007/s10620-021-06968-6. Epub 2021 Apr 9. Dig Dis Sci. 2022. PMID: 33835375 Review.
• A bioinformatic analysis of the inhibin-betaglycan-endoglin/CD105 network reveals prognostic value in multiple solid tumors.
  Listik E, Horst B, Choi AS, Lee NY, Győrffy B, Mythreye K. Listik E, et al. PLoS One. 2021 Apr 5;16(4):e0249558. doi: 10.1371/journal.pone.0249558. eCollection 2021. PLoS One. 2021. PMID: 33819300 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations Database